TABLE OF CONTENTS
Volume 13, Issue 1 (October 2006)
Papers
Biotechnology in Cuba: 20 years of scientific, social and economic progress FREE
Ernesto López Mola, Ricardo Silva, Boris Acevedo, José A Buxadó, Angel Aguilera and Luis Herrera
J Commer Biotechnol 13: 1-11; doi:10.1057/palgrave.jcb.3050038
Country-of-origin effect of VC investment in biotechnology companies
Siah Hwee Ang
J Commer Biotechnol 13: 12-19; doi:10.1057/palgrave.jcb.3050035
A retrospective prospective perspective on agricultural biotechnology ten years on
Martina Newell McGloughlin
J Commer Biotechnol 13: 20-27; doi:10.1057/palgrave.jcb.3050031
Using intellectual property to map the organisational evolution of firms: Tracing a biotechnology company from startup to bureaucracy to a multidivisional firm
Iraj Daizadeh
J Commer Biotechnol 13: 28-36; doi:10.1057/palgrave.jcb.3050032
When is patent infringement not patent infringement? Merck v Integra and the 'safe harbour'
Karen I Boyd
J Commer Biotechnol 13: 37-42; doi:10.1057/palgrave.jcb.3050036
Media coverage and biotechnology IPOs: Some Australian evidence
Paul Jens, Robert Brooks, Gina Nicoletti and Roslyn Russell
J Commer Biotechnol 13: 43-47; doi:10.1057/palgrave.jcb.3050033
Marketspace
Increased uptake of biologics in historically small molecule blockbuster-dominated therapeutic areas
Duncan A N Emerton and Mark J Belsey
J Commer Biotechnol 13: 48-51; doi:10.1057/palgrave.jcb.3050034
